Gemcitabine (Compound)

Synonyms:gemcitabine, 95058-81-4, 2',2'-Difluorodeoxycytidine, 2'-Deoxy-2',2'-difluorocytidine, Cytidine, 2'-deoxy-2',2'-difluoro-, dFdC, GEMCITABINE HYDROCHLORIDE, Gemcitabine free base, 103882-84-4, 2',2'-difluoro-2'-deoxycytidine, LY188011, 4-amino-1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2-dihydropyrimidin-2-one, LY-188011, 95058-81-4 (free base), 4-amino-1-((2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidin-2(1H)-one, NSC 613327, B76N6SBZ8R, LY 188011, 4-Amino-1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one, Gamcitabine, CHEBI:175901, NSC-613327, Gemcitabina, Gemcitabinum, Folfugem, Gemcel, Zefei, GemLip, 4-amino-1-((2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyrimidin-2(1H)-one, Gemcitabinum [INN-Latin], Gemcitabina [INN-Spanish], C9H11F2N3O4, Gemzar (hydrochloride), SR-05000001491, Gemcitabine (USAN/INN), UNII-B76N6SBZ8R, 2',2'-DiF-dC, Gemcitabine [USAN:INN:BAN], CCRIS 8984, MFCD00869720, HSDB 7567, 2vpp, gemcitabine (Gemzar), 4pd5, GEMCITABINE [MI], GEMCITABINE [INN], 2'-Deoxy-.beta.-D-2',2'-difluorocytidine, GEMCITABINE [HSDB], GEMCITABINE [USAN], CHEMBL888, GEMCITABINE [VANDF], SCHEMBL4295, GEMCITABINE [WHO-DD], GTPL4793, DTXSID3040487, 2'deoxy-2',2'-difluorocytidine, BCPP000219, BDBM429521, HMS2089P10, HMS3715N07, 2`-Deoxy-2`,2`-difluorocytidine, med.21724, Compound Gemcitabine, DL-215, s1714, AKOS015920303, Cytidine, 2'-deoxy-2',2'-difluoro-2'-Deoxy-.beta.-D-2',2'-difluorocytidine, BCP9000721, CCG-221183, CS-0643, DB00441, GS-3582, 4-Amino-1-[3,3-difluoro-4-hydroxy-5-(hydroxymethyl) tetrahydrofuran-2-yl]-1H-pyrimidin-2-one, NCGC00168784-02, NCGC00168784-08, NCGC00168784-12, BP-58640, HY-17026, G0544, SW199649-2, C07650, D02368, EN300-267822, AB01274777-01, AB01274777-02, AB01274777_05, AB01274777_06, Q414143, J-001056, SR-05000001491-1, SR-05000001491-2, BRD-K15108141-001-04-1, Z1741982024, 1-(2-deoxy-2,2-difluoro-|A-D-erythropentofuranosyl)cytosine, 4-amino-1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidin-2-one

Pubchem:PUBCHEM:60750

Id:21054913-c613-56a9-a890-a700f7913af8

Description:nan

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Gemcitabine's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Gemcitabine.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Gemcitabine.

Results found

Linked to

	Label	Description
	BRD-K15108141-001-04-1 Substance (Entity type)	A Substance
	DCSTRUCT ID 01283 Collection (Entity type)	DrugPage Collection: (DrugCentralID:01283; PubChem_CID:60750, FILE=drugcentral_drug_01283.json)
	gemcitabine (3f8f776c-b362-48ef-8b40-e766f9b60073) Collection (Entity type)	Metadatata for gemcitabine
	Gemcitabine negatively regulates PLK1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	uracil-mustard in similarity relationship with Gemcitabine Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Gemcitabine positively regulates SPRR1B Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Gemcitabine negatively regulates H2BC12 Gene Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Gemcitabine positively regulates KRT17 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Gemcitabine positively regulates KRT16 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	pralatrexate in similarity relationship with Gemcitabine Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS